Screening for nasopharyngeal carcinoma with an ELISA using the Epstein-Barr virus nuclear antigen, EBNA 1: a complementary test to the IgA/VCA immunofluorescence assay
- 30 April 1993
- journal article
- Published by Elsevier in Journal of Virological Methods
- Vol. 42 (1) , 45-51
- https://doi.org/10.1016/0166-0934(93)90175-q
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin.Annals of the Rheumatic Diseases, 1991
- Serum and salivary IgA antibodies against a defined epitope of the Epstein‐Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinomaInternational Journal of Cancer, 1990
- Improved Sensitivity of Detection by Avidin—Biotin Complex (ABC) Immunocytochemistry in Epstein-Barr Virus SerologyJournal of Medical Virology, 1989
- Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinomaInternational Journal of Cancer, 1988
- The Epstein-Barr Virus ProteinsPublished by Elsevier ,1988
- Antibodies to Peptides Detect New Hepatitis B Antigen: Serological Correlation with Hepatocellular CarcinomaScience, 1985
- Chemical synthesis of a polypeptide predicted from nucleotide sequence allows detection of a new retroviral gene productNature, 1980
- Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinomaInternational Journal of Cancer, 1976